Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate—Yemen during the transmission season

Acta Tropica

Volumn 162, Issue , 2016, Pages 174-179

  Alareqi, Lina M Q ^a   Mahdy, Mohammed A K ^b,c   Lau, Yee Ling ^a   Fong, Mun Yik ^a   Abdul Ghani, Rashad ^b,c   Mahmud, Rohela ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Yemen)

^c SANA A UNIVERSITY   (Yemen)

Author keywords

Antimalarial; Molecular marker; Plasmodium falciparum; Resistance; Yemen

Indexed keywords

ARTESUNATE; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; MOLECULAR MARKER; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; CARRIER PROTEIN; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE-ARTESUNATE;

ALLELE; ANTIMALARIAL AGENT; BIOMARKER; DNA; DRUG RESISTANCE; MUTATION; POLYMERASE CHAIN REACTION;

ALLELE; ARTICLE; CODON; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DNA SEQUENCE; DRUG EFFICACY; GENE MUTATION; GENE TARGETING; K13 GENE; MALARIA; MICROBIAL GENE; NONHUMAN; PFCRT GENE; PFDHFR GENE; PFDHPS GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; YEMEN; DRUG COMBINATION; DRUG RESISTANCE; GENETICS; GENOTYPE; MALARIA, FALCIPARUM; MUTATION;

YEMEN;

PLASMODIUM FALCIPARUM;

ALLELES; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; CROSS-SECTIONAL STUDIES; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; GENOTYPE; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PYRIMETHAMINE; SEQUENCE ANALYSIS, DNA; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; YEMEN;

EID: 84978284842     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2016.06.016     Document Type: Article

References (67)

1. Abdul-Ghani, R., Farag, H.F., Allam, A.F., Shawky, S.M., Al-Mekhlafi, A.M., Mutant Plasmodium falciparum chloroquine resistance transporter in Hodeidah, Yemen: association with parasitologic indices and treatment-seeking behaviors. Acta Trop. 128 (2013), 473–478.
2. Adagu, I.S., Warhurst, D.C., Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology 123 (2001), 219–224.
3. Adeel, A.A., Saeed, N.A., Aljasari, A., Almohager, A.M., Galab, M.H., AlMahdi, A., Mahammed, M.H., AlDarsi, M., Salaeah, Y.A., Atta, H., Zamani, G., Warsame, M., Barrette, A., Mohammady, H.E., Nada, R.A., High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen. Malar. J., 14, 2015, 449.
4. Al-Hamidhi, S., Mahdy, M., Al-Hashami, Z., Al-Farsi, H., Al-Mekhlafi, A.M., Idris, M.A., Beja-Pereira, A., Babiker, H., Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen. Malar. J., 12, 2013, 244.
5. Al-Kabsi, A.M., Al-Shamahy, H.A., Al-Harazy, A.H., Harmal, N.S., The therapeutic efficacy of sulfadoxine/pyrimethamine against Plasmodium falciparum in Yemen. Med. Princ. Pract. 18 (2009), 62–66.
6. Al-Mekhlafi, A.M., Mahdy, M., Al-Mekhlafi, H.M., Azazy, A.A., Fong, M.Y., High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy. Parasit. Vectors, 4, 2011, 94.
7. Alareqi, L.M., Mahdy, M.A., Lau, Y.L., Fong, M.Y., Abdul-Ghani, R., Ali, A.A., Cheong, F.W., Tawfek, R., Mahmud, R., Field evaluation of a PfHRP-2/pLDH rapid diagnostic test and light microscopy for diagnosis and screening of falciparum malaria during the peak seasonal transmission in an endemic area in Yemen. Malar. J., 15, 2016, 49.
8. Alifrangis, M., Lusingu, J.P., Mmbando, B., Dalgaard, M.B., Vestergaard, L.S., Ishengoma, D., Khalil, I.F., Theander, T.G., Lemnge, M.M., Bygbjerg, I.C., Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581 G mutation in the P. falciparum dihydropteroate synthase gene. Am. J. Trop. Med. Hyg. 80 (2009), 523–527.
9. Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505 (2014), 50–55.
10. Ashley, E.A., Dhorda, M., Fairhurst, R.M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J.M., Mao, S., Sam, B., Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371 (2014), 411–423.
11. Babiker, H.A., Pringle, S.J., Abdel-Muhsin, A., Mackinnon, M., Hunt, P., Walliker, D., High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J. Infect. Dis. 183 (2001), 1535–1538.
12. Babiker, H.A., Satti, G., Ferguson, H., Bayoumi, R., Walliker, D., Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop. 94 (2005), 260–268.
13. Babiker, H.A., Seasonal fluctuation of drug-resistant malaria parasites: a sign of fitness cost. Trends Parasitol. 25 (2009), 351–352.
14. Bamaga, O., Mahdy, M.A., Lim, Y.A., Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen. Malar. J., 14, 2015, 1.
15. Bamaga, O., Mahdy, M.A., Lim, Y.A., Survey of chloroquine-resistant mutations in the Plasmodium falciparum pfcrt and pfmdr-1 genes in Hadhramout, Yemen. Acta Trop. 149 (2015), 59–63.
16. Bashrahil, K., Bingouth, A., Baruzaig, A., Antimalarial drugs: availability and mode of prescribing in Mukalla, Yemen. East. Mediterr. Health J. 16 (2010), 146–150.
17. Bin Ghouth, A.S., Availability and prescription practice of anti-malaria drugs in the private health sector in Yemen. J. Infect. Dev. Ctries. 7 (2013), 404–412.
18. Dajem, S.M.B., Al-Farsi, H.M., Al-Hashami, Z.S., Al-Sheikh, A.A.H., Al-Qahtani, A., Babiker, H.A., Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia. Am. J. Trop. Med. Hyg. 86 (2012), 782–788.
19. Djimdé, A., Doumbo, O.K., Cortese, J.F., Kayentao, K., Doumbo, S., Diourté, Y., Coulibaly, D., Dicko, A., Su X.-z. Nomura, T., A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344 (2001), 257–263.
20. Dondorp, A.M., Nosten, F., Yi, P., Das, D., Phyo, A.P., Tarning, J., Lwin, K.M., Ariey, F., Hanpithakpong, W., Lee, S.J., Ringwald, P., Silamut, K., Imwong, M., Chotivanich, K., Lim, P., Herdman, T., An, S.S., Yeung, S., Singhasivanon, P., Day, N.P., Lindegardh, N., Socheat, D., White, N.J., Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361 (2009), 455–467.
21. Duraisingh, M.T., Jones, P., Sambou, I., von Seidlein, L., Pinder, M., Warhurst, D.C., The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 108 (2000), 13–23.
22. Duraisingh, M.T., Roper, C., Walliker, D., Warhurst, D.C., Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol. 36 (2000), 955–961.
23. Escalante, A.A., Smith, D.L., Kim, Y., The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum. Trends Parasitol. 25 (2009), 557–563.
24. Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., Ursos, L.M., Sidhu, A.B., Naude, B., Deitsch, K.W., Su, X.Z., Wootton, J.C., Roepe, P.D., Wellems, T.E., Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6 (2000), 861–871.
25. Hall, T.A., BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. 41 (1999), 95–98.
26. Happi, C.T., Gbotosho, G.O., Folarin, O.A., Sowunmi, A., Hudson, T., O'Neil, M., Milhous, W., Wirth, D.F., Oduola, A.M., Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 53 (2009), 888–895.
27. Hastings, I.M., Watkins, W.M., Intensity of malaria transmission and the evolution of drug resistance. Acta Trop. 94 (2005), 218–229.
28. Hastings, I.M., Watkins, W.M., White, N.J., The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357 (2002), 505–519.
29. Kamau, E., Campino, S., Amenga-Etego, L., Drury, E., Ishengoma, D., Johnson, K., Mumba, D., Kekre, M., William, Y., Mead, D., K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J. Infect. Dis. 211 (2014), 1352–1355.
30. Kamugisha, E., Bujila, I., Lahdo, M., Pello-Esso, S., Minde, M., Kongola, G., Naiwumbwe, H., Kiwuwa, S., Kaddumukasa, M., Kironde, F., Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda—a reflection of differences in policies regarding withdrawal of chloroquine?. Acta Trop. 121 (2012), 148–151.
31. Kamugisha, E., Jing, S., Minde, M., Kataraihya, J., Kongola, G., Kironde, F., Swedberg, G., Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania. Malar. J., 11, 2012, 58.
32. Kiwuwa, M.S., Byarugaba, J., Wahlgren, M., Kironde, F., Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P falciparum clinical isolates collected from Uganda. Acta Trop. 125 (2013), 269–275.
33. Kublin, J.G., Dzinjalamala, F.K., Kamwendo, D.D., Malkin, E.M., Cortese, J.F., Martino, L.M., Mukadam, R.A., Rogerson, S.J., Lescano, A.G., Molyneux, M.E., Winstanley, P.A., Chimpeni, P., Taylor, T.E., Plowe, C.V., Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185 (2002), 380–388.
34. Kublin, J.G., Cortese, J.F., Njunju, E.M., Mukadam, R.A.G., Wirima, J.J., Kazembe, P.N., Djimdé, A.A., Kouriba, B., Taylor, T.E., Plowe, C.V., Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187 (2003), 1870–1875.
35. Laufer, M.K., Thesing, P.C., Eddington, N.D., Masonga, R., Dzinjalamala, F.K., Takala, S.L., Taylor, T.E., Plowe, C.V., Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 355 (2006), 1959–1966.
36. Malmberg, M., Ngasala, B., Ferreira, P.E., Larsson, E., Jovel, I., Hjalmarsson, A., Petzold, M., Premji, Z., Gil, J.P., Bjorkman, A., Martensson, A., Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania. Malar. J., 12, 2013, 103.
37. Mang'era, C.M., Mbai, F.N., Omedo, I.A., Mireji, P.O., Omar, S.A., Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya. Acta Trop. 123 (2012), 202–207.
38. Mekonnen, S.K., Aseffa, A., Berhe, N., Teklehaymanot, T., Clouse, R.M., Gebru, T., Medhin, G., Velavan, T.P., Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar. J., 13, 2014, 244.
39. Modrzynska, K.K., Genetics of Drug Resistance in Malaria: Identification of Genes Conferring Chloroquine and Artemisinin Resistance in Rodent Malaria Parasite Plasmodium Chabaudi. 2011, University of Edinburgh, Edinburgh.
40. Mohammed, A., Ndaro, A., Kalinga, A., Manjurano, A., Mosha, J.F., Mosha, D.F., van Zwetselaar, M., Koenderink, J.B., Mosha, F.W., Alifrangis, M., Reyburn, H., Roper, C., Kavishe, R.A., Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania. Malar. J., 12, 2013, 415.
41. Mu, J., Ferdig, M.T., Feng, X., Joy, D.A., Duan, J., Furuya, T., Subramanian, G., Aravind, L., Cooper, R.A., Wootton, J.C., Xiong, M., Su, X.Z., Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 49 (2003), 977–989.
42. Mubjer, R.A., Adeel, A.A., Chance, M.L., Hassan, A.A., Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen : baseline data and implications. Malar. J., 10, 2011, 245.
43. Mwai, L., Ochong, E., Abdirahman, A., Kiara, S.M., Ward, S., Kokwaro, G., Sasi, P., Marsh, K., Borrmann, S., Mackinnon, M., Chloroquine resistance before and after its withdrawal in Kenya. Malar. J., 8, 2009, 106.
44. National Malaria Control Program/Ministry of Health and Population, Yemen's National Malaria Control and Elimination Strategic Plan 2006–2010. 2006, NMCP, Sana'a.
45. National Malaria Control Program/Ministry of Health and Population, Yemen's National Malaria Control and Elimination Strategic Plan 2011–2015. 2010, NMCP, Sana'a.
46. National Malaria Control Program/Ministry of Health and Population, National Malaria Control Program Report., 2013, NMCP, Sana'a.
47. Nsobya, S.L., Kiggundu, M., Nanyunja, S., Joloba, M., Greenhouse, B., Rosenthal, P.J., In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob. Agents Chemother. 54 (2010), 1200–1206.
48. Pearce, R.J., Drakeley, C., Chandramohan, D., Mosha, F., Roper, C., Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob. Agents Chemother. 47 (2003), 1347–1354.
49. Peterson, D.S., Walliker, D., Wellems, T.E., Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U.S.A. 85 (1988), 9114–9118.
50. Phyo, A.P., Nkhoma, S., Stepniewska, K., Ashley, E.A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A.M., Lwin, K.M., Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379 (2012), 1960–1966.
51. Picot, S., Olliaro, P., de Monbrison, F., Bienvenu, A.L., Price, R.N., Ringwald, P., A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar. J., 8, 2009, 89.
52. Plowe, C.V., PCR-Allele-Specific Restriction Analysis (ASRA): Protocols for Plasmodium Falciparum Drug Resistance Mutation Analyses. 2002, University of Maryland (Available at http://medschool.umaryland.edu/malaria/protocols.asp).
53. Poyomtip, T., Suwandittakul, N., Sitthichot, N., Khositnithikul, R., Tan-ariya, P., Mungthin, M., Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum. Malar. J., 11, 2012, 7.
54. Raman, J., Mauff, K., Muianga, P., Mussa, A., Maharaj, R., Barnes, K.I., Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. PLoS One, 6, 2011, e25992.
55. Singh, B., Bobogare, A., Cox-Singh, J., Snounou, G., Abdullah, M.S., Rahman, H.A., A genus-and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am. J. Trop. Med. Hyg. 60 (1999), 687–692.
56. Sisowath, C., Stromberg, J., Martensson, A., Msellem, M., Obondo, C., Bjorkman, A., Gil, J.P., In vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191 (2005), 1014–1017.
57. Talisuna, A.O., Erhart, A., Samarasinghe, S., Van Overmeir, C., Speybroeck, N., D'Alessandro, U., Malaria transmission intensity and the rate of spread of chloroquine resistant falciparum: why have theoretical models generated conflicting results?. Infect. Genet. Evol. 26 (2006), 241–248.
58. Thomsen, T.T., Ishengoma, D.S., Mmbando, B.P., Lusingu, J.P., Vestergaard, L.S., Theander, T.G., Lemnge, M.M., Bygbjerg, I.C., Alifrangis, M., Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy. Am. J. Trop. Med. Hyg. 85 (2011), 979–983.
59. Thomsen, T.T., Madsen, L.B., Hansson, H.H., Tomas, E.V., Charlwood, D., Bygbjerg, I.C., Alifrangis, M., Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique. Am. J. Trop. Med. Hyg. 88 (2013), 536–541.
60. Tinto, H., Ouedraogo, J.B., Zongo, I., van Overmeir, C., van Marck, E., Guiguemde, T.R., D'Alessandro, U., Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am. J. Trop. Med. Hyg. 76 (2007), 608–613.
61. Venkatesan, M., Gadalla, N.B., Stepniewska, K., Dahal, P., Nsanzabana, C., Moriera, C., Price, R.N., Martensson, A., Rosenthal, P.J., Dorsey, G., Sutherland, C.J., Guerin, P., Davis, T.M., Menard, D., Adam, I., Ademowo, G., Arze, C., Baliraine, F.N., Berens-Riha, N., Bjorkman, A., Borrmann, S., Checchi, F., Desai, M., Dhorda, M., Djimde, A.A., El-Sayed, B.B., Eshetu, T., Eyase, F., Falade, C., Faucher, J.F., Froberg, G., Grivoyannis, A., Hamour, S., Houze, S., Johnson, J., Kamugisha, E., Kariuki, S., Kiechel, J.R., Kironde, F., Kofoed, P.E., LeBras, J., Malmberg, M., Mwai, L., Ngasala, B., Nosten, F., Nsobya, S.L., Nzila, A., Oguike, M., Otienoburu, S.D., Ogutu, B., Ouedraogo, J.B., Piola, P., Rombo, L., Schramm, B., Some, A.F., Thwing, J., Ursing, J., Wong, R.P., Zeynudin, A., Zongo, I., Plowe, C.V., Sibley, C.H., Group, A.M.M.S., Wwarn, A.L., Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am. J. Trop. Med. Hyg., 91, 2014, 833843.
62. Wang, P., Read, M., Sims, P.F., Hyde, J.E., Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23 (1997), 979–986.
63. Wellems, T.E., Plowe, C.V., Chloroquine-resistant malaria. J. Infect. Dis. 184 (2001), 770–776.
64. White, N.J., Antimalarial drug resistance. J. Clin. Invest. 113 (2004), 1084–1092.
65. Wongsrichanalai, C., Pickard, A.L., Wernsdorfer, W.H., Meshnick, S.R., Epidemiology of drug-resistant malaria. Lancet Infec. Dis. 2 (2002), 209–218.
66. World Health Organization, World Malaria Report 2014., 2014, WHO, Geneva.
67. World Health Organization, Guidelines for the Treatment of Malaria. 3rd ed., 2015, WHO, Geneva.